van Oort Douglas M

Neogenomics Inc.

Director

Avg. Two Year Performance

120% Avg. Purchase Return 48% Compound

(8%) Avg. Sale Return (4%) Compound

Holdings: 2.48M shares

Last Three Months: 24-Aug-24 -- 23-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Medical Laboratories & Research

Health Services

Two Year Chart

24-Nov-22 -- 23-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions